Baosheng Li

机构：Qingdao University, Academy of Medical Sciences, Shandong University, Guangxi Minzu University, Shandong Tumor Hospital, Affiliated Hospital of Qingdao University, Affiliated Hospital of Youjiang Medical University for Nationalities, Shandong First Medical University · ORCID：0000-0002-5390-7269

发表论文 136 篇 · 总被引 8333 次 · h-index 28

代表论文

• Neoadjuvant SHR-1701 with or without chemotherapy in unresectable stage III non-small-cell lung cancer: A proof-of-concept, phase 2 trial (2024 · Cancer Cell · 被引 59)
• Thoracic Radiotherapy Improves the Survival in Patients With EGFR -Mutated Oligo-Organ Metastatic Non–Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors: A Multicenter, Randomized, Controlled, Phase III Trial (2024 · Journal of Clinical Oncology · 被引 52)
• LeSAM: Adapt Segment Anything Model for Medical Lesion Segmentation (2024 · IEEE Journal of Biomedical and Health Informatics · 被引 29)
• ML385 promotes ferroptosis and radiotherapy sensitivity by inhibiting the NRF2-SLC7A11 pathway in esophageal squamous cell carcinoma (2024 · Medical Oncology · 被引 28)
• Concurrent chemoradiotherapyof different radiation doses and different irradiation fields for locally advanced thoracic esophageal squamous cell carcinoma: A randomized, multicenter, phase III clinical trial (2024 · 癌症：英文版 · 被引 19)
• A combined nomogram based on radiomics and hematology to predict the pathological complete response of neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma (2024 · BMC Cancer · 被引 18)